New EZH1/2 Inhibitors

Catalog No. Product Name Information
E1497 Tulmimetostat Tulmimetostat (CPI-0209) is an orally bioavailable and selective inhibitor of EZH2 that has therapeutic potential for androgen receptor-dependent prostate cancer.
All EZH1/2 Inhibitors